EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence of silent plasmid-mediated fosfomycin-resistance genes among clinical isolates of fosfomycin-susceptible Escherichia coli

Rojan I Albazaz, Haliz S Hasan, Najim A Yassin

The Journal of Infection in Developing Countries · 31.03.2026 · 20 (03) · 366-373

DOI: 10.3855/jidc.21476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 31.03.2026. Verfasst von Rojan I Albazaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology and Histology, University of Duhok, Kurdistan Region, Iraq. Hauptthemen laut MEDLINE: Fosfomycin, Escherichia coli, Anti-Bacterial Agents, Plasmids. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Infections caused by Escherichia coli place a considerable burden on both patients and healthcare facilities. This study aims to investigate the prevalence and molecular detection of silent plasmid-mediated fosfomycin-resistance (PMFR) genes among fosfomycin-sensitive, extended-spectrum β-lactamase (ESβL)- producing E. coli isolates. Methodology: Clinical samples of E. coli were collected from various sources and hospitals in Duhok‚ Iraq‚ from December 2020 to April 2021. Standard microbiological techniques and the Vitek II system were used to identify E. coli, which was further confirmed through species-specific genes. The Kirby-Bauer method was employed for antimicrobial sensitivity testing, followed by the detection of targeted PMFR and genes using conventional polymerase chain reaction (PCR).

Results

High resistance levels were observed against ampicillin, ceftriaxone, tetracycline, and ciprofloxacin, whereas a lower resistance rate was detected for carbapenems. Notably, all the isolates were susceptible to fosfomycin. Four isolates tested positive for fosA3, four were positive for fosA, and 16 were positive for the blaCTX-M9 gene. Within the isolates, three co-harbored fosA3, fosA, and blaCTX-M9 genes, while one isolate co-expressed fosA3 and blaCTX-M9 genes. The distribution of these genes, both individually and co-harbored, was observed across all clinical samples analyzed, except those derived from blood and sputum.

Conclusions

The dissemination of silent PMFR genes could pose a future risk for public health under the selective pressure of antibiotics, especially extended-spectrum beta-lactams, for a long time, or transfer to other bacteria, potentially leading to the activation of these genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FosfomycinEscherichia coliAnti-Bacterial AgentsPlasmidsEscherichia coli InfectionsDrug Resistance, BacterialHumansMicrobial Sensitivity Testsbeta-LactamasesPrevalenceIraq

Stichwörter der Autor:innen

E. coliclinical samplesfosfomycinsilent genes

Substanzen

FosfomycinAnti-Bacterial Agentsbeta-Lactamases

Autor:innen und Institutionen

  • Department of Medical Biology and Histology, University of Duhok, Kurdistan Region, Iraq.
  • Department of Medical Microbiology, University of Duhok, Kurdistan Region, Iraq.
  • Department of Medical Microbiology, College of Medicine, University of Duhok, Kurdistan Region, Iraq.

Zitieren

APA

Albazaz, R. I., Hasan, H. S., & Yassin, N. A. (2026). Prevalence of silent plasmid-mediated fosfomycin-resistance genes among clinical isolates of fosfomycin-susceptible Escherichia coli. The Journal of Infection in Developing Countries, 20(03), 366-373. https://doi.org/10.3855/jidc.21476

Vancouver

Albazaz RI, Hasan HS, Yassin NA. Prevalence of silent plasmid-mediated fosfomycin-resistance genes among clinical isolates of fosfomycin-susceptible Escherichia coli. The Journal of Infection in Developing Countries. 2026;20(03):366-373. doi:10.3855/jidc.21476

BibTeX
@article{Albazaz2026,
  author = {Albazaz, Rojan I and Hasan, Haliz S and Yassin, Najim A},
  title = {Prevalence of silent plasmid-mediated fosfomycin-resistance genes among clinical isolates of fosfomycin-susceptible Escherichia coli},
  journal = {The Journal of Infection in Developing Countries},
  year = {2026},
  volume = {20},
  number = {03},
  pages = {366--373},
  doi = {10.3855/jidc.21476}
}
Kostenlos starten →